JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Excellent photocatalytic degradation activities of ordered mesoporous anatase TiO2-SiO2 nanocomposites to various organic contaminants.

Ordered 2-D hexagonal mesoporous TiO(2)-SiO(2) nanocomposites consisted of anatase TiO(2) nanocrystals and amorphous SiO(2) nanoparticles, with large mesochannels and high specific surface areas, have been extensively and detailedly evaluated using various cationic dyes (methylene blue, safranin O, crystal violet, brilliant green, basic fuchsin and rhodamine-6G), anionic dyes (acid fuchsin, orange II, reactive brilliant red X3B and acid red 1) and microcystin-LR. We use mesoporous 80TiO(2)-20SiO(2)-900 for the degradation of cationic dyes and MC-LR, due to the dominant adsorption of SiOH groups and synergistic role of coupled adsorption and photocatalytic oxidation. For anionic dyes, due to the adsorption results predominantly from TiOH groups, our strategy realizes the enhanced photocatalytic oxidation by strong surface acids and larger available specific surface area. Based on this, we prepared 90TiO(2)-10SiO(2)-700 to degrade them. The results show that our samples exhibit excellent degradation activities to all the contaminants, which are much higher than that of P25 photocatalyst. The dyes are not only decolorized promptly but degraded readily as well. It is strongly indicated that our mesoporous nanocomposites are considerably stable and reusable. These results demonstrate that our mesoporous TiO(2)-SiO(2) nanocomposites present extensive and promising application in the fast and highly efficient degradation of various organic pollutants.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app